Cargando…
Suspected Neratinib Macular Toxicity Presenting As Macular Telangiectasia Type II
The purpose of this case report is to present the first case of neratinib maculopathy. We describe the initial presentation, baseline characteristics, imaging findings, and outcomes. The case report is accompanied by a thorough literature review including possible mechanisms of tyrosine kinase inhib...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Cureus
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9941022/ https://www.ncbi.nlm.nih.gov/pubmed/36824546 http://dx.doi.org/10.7759/cureus.33964 |